Volume 21 Number 9
30 September 2019

Home > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 9, 30 September

Bani-Sadr A, Eker OF, Berner LP, Ameli R, Hermier M, Barritault M, Meyronet D, Guyotat J, Jouanneau E, Honnorat J, Ducray F, Berthezene Y.
Conventional MRI radiomics in patients with suspected early- or pseudo-progression.
Neurooncol Adv. 2019 Sep 1, 2019;1(1):vdz019. doi: 10.1093/noajnl/vdz019. PMID: 32642655. Observational study. ˍ

Weller J, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Hau P, Krex D, Grauer O, Goldbrunner R, Bähr O, Uhl M, Seidel C, Tabatabai G, Brehmer S, Bullinger L, Galldiks N, Schaub C, Kebir S, Stummer W, Simon M, Fimmers R, Coch C, Glas M, Herrlinger U, Schäfer N.
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol. 2019 Sep 2, 2019;20(10):1444-1453. doi: 10.1016/S1470-2045(19)30502-9. PMID: 31488360. Interventional study. ˍ

Narayan V, Sugur H, Jaiswal J, Arvinda HR, Arivazhagan A, Somanna S, Santosh V.
Medulloblastoma: Distinctive Histo-Molecular Correlation with Clinical Profile, Radiologic Characteristics, and Surgical Outcome.
Pediatr Neurosurg. 2019 Sep 3, 2019;54(5):329-340. doi: 10.1159/000501913. PMID: 31480064. Observational study. ˍ

Schneider M, Potthoff AL, Keil VC, Güresir Á, Weller J, Borger V, Hamed M, Waha A, Vatter H, Güresir E, Herrlinger U, Schuss P.
Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection.
J Neurooncol. 2019 Sep 4, 2019;145(1):143-150. doi: 10.1007/s11060-019-03281-1. PMID: 31485921. Observational study. ˍ

Akimoto J, Fukami S, Suda T, Ichikawa M, Haraoka R, Kohno M, Shishido-Hara Y, Nagao T, Kuroda M.
First autopsy analysis of the efficacy of intra-operative additional photodynamic therapy for patients with glioblastoma.
Brain Tumor Pathol. 2019 Sep 5, 2019;36(4):144-151. doi: 10.1007/s10014-019-00351-0. PMID: 31487014. Observational study. ˍ

Kim N, Chang JS, Wee CW, Kim IA, Chang JH, Lee HS, Kim SH, Kang SG, Kim EH, Yoon HI, Kim JW, Hong CK, Cho J, Kim E, Kim TM, Kim YJ, Park CK, Kim JW, Kim CY, Choi SH, Kim JH, Park SH, Choe G, Lee ST, Kim IH, Suh CO.
Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma.
Strahlenther Onkol. 2019 Sep 5, 2020;196(1):58-69. doi: 10.1007/s00066-019-01512-y. PMID: 31489457. Observational study. ˍ

Swinnen J, Gelin G, Fransis S, Vandevenne J, Van Cauter S.
Glioblastoma with extracranial parotid, lymph node, and pulmonary metastases: a case report.
Radiol Case Rep. 2019 Sep 5, 2019;14(11):1334-1347. doi: 10.1016/j.radcr.2019.08.011. PMID: 31516649. Case report. ˍ

Bashir A, Mathilde Jacobsen S, Mølby Henriksen O, Broholm H, Urup T, Grunnet K, Andrée Larsen V, Møller S, Skjøth-Rasmussen J, Skovgaard Poulsen H, Law I.
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).
Neuro Oncol. 2019 Sep 6, 2019;21(12):1595-1606. doi: 10.1093/neuonc/noz166. PMID: 31618420. Observational study. ˍ

Eichberg DG, Di L, Shah AH, Luther EM, Richardson AM, Sarkiss CA, Ivan ME, Komotar RJ.
Brain Tumor Surgery is Safe in Octogenarians and Nonagenarians: A Single Surgeon 741 Patient Series.
World Neurosurg. 2019 Sep 7, 2019;132:e185-e192. doi: 10.1016/j.wneu.2019.08.219. PMID: 31505286. Observational study. ˍ

Foster H, Piper K, DePledge L, Li HF, Scanlan J, Jae-Guen Y, Boeckh M, Cobbs C.
Human cytomegalovirus seropositivity is associated with decreased survival in glioblastoma patients.
Neurooncol Adv. 2019 Sep 7, 2019;1(1):vdz020. doi: 10.1093/noajnl/vdz020. PMID: 32642656. Observational study. ˍ

Opoku-Darko M, Eagles ME, Cadieux M, Isaacs AM, Kelly JJP.
Natural History and Growth Patterns of Incidentally Discovered Diffusely Infiltrating Low-Grade Gliomas: A Volumetric Study.
World Neurosurg. 2019 Sep 7, 2019;132:e133-e139. doi: 10.1016/j.wneu.2019.08.235. PMID: 31505287. Observational study. ˍ

Alameda F, Velarde JM, Carrato C, Vidal N, Arumí M, Naranjo D, Martinez-Garcia M, Ribalta T, Balañá C.
Prognostic value of stem cell markers in glioblastoma.
Biomarkers. 2019 Sep 8, 2019;24(7):677-683. doi: 10.1080/1354750X.2019.1652345. PMID: 31496301. Laboratory investigation. ˍ

Shieh LT, Guo HR, Chang YK, Lu NM, Ho SY.
Clinical implications of multiple glioblastomas: An analysis of prognostic factors and survival to distinguish from their single counterparts.
J Formos Med Assoc. 2019 Sep 10, 2020;119(3):728-734. doi: 10.1016/j.jfma.2019.08.024. PMID: 31515159. Observational study. ˍ

Pallud J, Roux A, Mellerio C.
Glioma Resection Unmasks Eloquent Brain Areas.
World Neurosurg. 2019 Sep 11, 2019;132:251-252. doi: 10.1016/j.wneu.2019.09.012. PMID: 31520765. Observational study. ˍ

Chen X, Zhao C, Zhao Z, Wang H, Fang Z.
Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns.
Front Genet. 2019 Sep 12, 2019;10:786
. doi: 10.3389/fgene.2019.00786. PMID: 31572431. Observational study. ˍ

Sautter L, Hofheinz R, Tuettenberg J, Grimm M, Vajkoczy P, Groden C, Schmieder K, Hochhaus A, Wenz F, Giordano FA.
Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma.
Oncology. 2019 Sep 12, 2020;98(1):16-22. doi: 10.1159/000502483. PMID: 31514200. Interventional study. ˍ

Wang J, Liu J, Sun G, Meng H, Wang J, Guan Y, Yin Y, Zhao Z, Dong X, Yin S, Li H, Cheng Y, Wu H, Wu A, Yu X, Chen L.
Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells.
Cancer Lett. 2019 Sep 12, 2019;466:1-12. doi: 10.1016/j.canlet.2019.09.004. PMID: 31521694. Laboratory investigation. ˍ

Xue Y, Cooper G, Cai C, Lu S, Hu B, Ma X, Lu X.
Tumour-specific Causal Inference Discovers Distinct Disease Mechanisms Underlying Cancer Subtypes.
Sci Rep. 2019 Sep 13, 2019;9(1):13225. doi: 10.1038/s41598-019-48318-7. PMID: 31519988. Laboratory investigation. ˍ

Di Ieva A, Magnussen JS, McIntosh J, Mulcahy MJ, Pardey M, Choi C.
Magnetic Resonance Spectroscopic Assessment of Isocitrate Dehydrogenase Status in Gliomas: The New Frontiers of Spectrobiopsy in Neurodiagnostics.
World Neurosurg. 2019 Sep 14, 2020;133:e421-e427. doi: 10.1016/j.wneu.2019.09.040. PMID: 31526886. Observational study. ˍ

Proctor DT, Huang J, Lama S, Albakr A, Van Marle G, Sutherland GR.
Tumor-associated macrophage infiltration in meningioma.
Neurooncol Adv. 2019 Sep 19. 2019;1(1):vdz018. doi: 10.1093/noajnl/vdz018. PMID: 32642654. Laboratory investigation. ˍ

Pala A, Nadji-Ohl M, Faust K, Rückriegel S, Roder C, von der Brelie C, Forster MT, Löbel F, Schommer S, Löhr M, Grübel N, Rothenbacher D, König R, Engelke J, Schmitz B, Wirtz CR, Senft C, Rohde V, Tatagiba M, Ernestus RI, Vajkoczy P, Ganslandt O, Nagel G, Coburger J.
Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio Project.
J Neurol Surg A Cent Eur Neurosurg. 2019 Sep 24, 2020;81(1):48-57. doi: 10.1055/s-0039-1693650. PMID: 31550737. Observational study. ˍ

Verburg N, Koopman T, Yaqub MM, Hoekstra OS, Lammertsma AA, Barkhof F, Pouwels PJW, Reijneveld JC, Heimans JJ, Rozemuller AJM, Bruynzeel AME, Lagerwaard F, Vandertop WP, Boellaard R, Wesseling P, de Witt Hamer PC.
Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
Neuro Oncol. 2019 Sep 24, 2020;22(3):412-422. doi: 10.1093/neuonc/noz180. PMID: 31550353. Interventional study. ˍ

Faltermeier C, Chai T, Syed S, Lau N, Elkaim L, Ibrahim G, Wang A, Weil A, Bendel A, Fallah A, Tu A.
Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER database.
PLoS One. 2019 Sep 25, 2019;14(9):e0223051. doi: 10.1371/journal.pone.0223051. PMID: 31553771. Observational study. ˍ

Wang L, Babikir H, Müller S, et al.
The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation.
Cancer Discov. 2019 Sep 25, 2019;9(12):1708–1719. doi:10.1158/2159-8290.CD-19-0329. PMID: 31554641. Laboratory investigation. ˍ

Gerstner E, Emblem KE, Chang K, Vakulenko-Lagun B, Yen YF, Beers AL, Dietrich J, Plotkin SR, Catana C, Hooker JM, Duda DG, Rosen B, Kalpathy-Cramer J, Jain RK, Batchelor T.
Bevacizumab reduces permeability and concurrent temozolomide delivery in a subset of patients with recurrent glioblastoma.
Clin Cancer Res. 2019 Sep 26, 2020;26(1):206-212. doi: 10.1158/1078-0432.CCR-19-1739. PMID: 31558474. Interventional study. ˍ

Ahn S, Park JS, Song JH, Jeun SS, Hong YK.
Effect of a Time Delay for Concomitant Chemoradiation After Surgery for Newly Diagnosed Glioblastoma: A Single-Institution Study with Subgroup Analysis According to the Extent of Tumor Resection.
World Neurosurg. 2019 Sep 27, 2020;133:e640-e645. doi: 10.1016/j.wneu.2019.09.122. PMID: 31568907. Observational study. ˍ

Su X, Chen N, Sun H, Liu Y, Yang X, Wang W, Zhang S, Tan Q, Su J, Gong Q, Yue Q.
Automated Machine Learning Based on Radiomics Features Predicts H3 K27M Mutation in Midline Gliomas of the Brain.
Neuro Oncol.
2019 Sep 29, 2020;22(3):393-401. doi: 10.1093/neuonc/noz184. PMID: 31563963. Observational study. ˍ